Drugs Made In America Acquisition Corp. — All Filings
57 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B4
8-A12B
8-K
CERT
CORRESP
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PRE 14A | PROXY STATEMENT | 0001213900-26-035624 | Mar 27, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-035502 | Mar 27, 2026 | Mar 23, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-024762 | Mar 6, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-024392 | Mar 6, 2026 | Feb 28, 2026 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-112096 | Nov 18, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-111704 | Nov 18, 2025 | Oct 8, 2025 |
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-25-111208 | Nov 17, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0001393825-25-000076 | Nov 12, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-076681 | Aug 14, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001072613-25-000596 | Aug 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-046061 | May 20, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001604488-25-000134 | May 15, 2025 | — |
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-25-044303 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001076809-25-000052 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0001326389-25-000192 | May 15, 2025 | — |
| SCHEDULE 13G | — | 0001072613-25-000381 | May 14, 2025 | — |
| SCHEDULE 13G | — | 0001393825-25-000017 | May 14, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-026240 | Mar 31, 2025 | Dec 31, 2024 |
| SCHEDULE 13D | — | 0001213900-25-019525 | Mar 3, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-016702 | Feb 25, 2025 | Feb 18, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-016602 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001213900-25-015020 | Feb 18, 2025 | — |
| 4 | — | 0001213900-25-015019 | Feb 18, 2025 | — |
| 4 | — | 0001213900-25-010195 | Feb 4, 2025 | Jan 29, 2025 |
| 4 | — | 0001213900-25-010193 | Feb 4, 2025 | Jan 29, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-010079 | Feb 4, 2025 | Jan 29, 2025 |
| 4 | — | 0001213900-25-009602 | Feb 3, 2025 | Jan 29, 2025 |
| 4 | — | 0001213900-25-009600 | Feb 3, 2025 | Jan 29, 2025 |
| 4 | — | 0001213900-25-009597 | Feb 3, 2025 | Jan 29, 2025 |
| 4 | — | 0001213900-25-009595 | Feb 3, 2025 | Jan 29, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-008377 | Jan 30, 2025 | Jan 27, 2025 |
| 424B4 | PROSPECTUS | 0001213900-25-007724 | Jan 29, 2025 | — |
| EFFECT | — | 9999999995-25-000196 | Jan 27, 2025 | — |
| CORRESP | — | 0001213900-25-005828 | Jan 23, 2025 | — |
| CORRESP | — | 0001213900-25-005825 | Jan 23, 2025 | — |
| POS AM | REGISTRATION STATEMENT | 0001213900-25-005176 | Jan 22, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT | 0001213900-25-003137 | Jan 14, 2025 | — |
| 3 | — | 0001213900-25-002358 | Jan 10, 2025 | Jan 7, 2025 |
| 3 | — | 0001213900-25-002356 | Jan 10, 2025 | Jan 7, 2025 |
| 3 | — | 0001213900-25-002353 | Jan 10, 2025 | Jan 7, 2025 |
| 3 | — | 0001213900-25-002351 | Jan 10, 2025 | Jan 7, 2025 |
| 3 | — | 0001213900-25-002349 | Jan 10, 2025 | Jan 7, 2025 |
| 3 | — | 0001213900-25-002347 | Jan 10, 2025 | Jan 7, 2025 |
| CERT | — | 0001354457-25-000013 | Jan 8, 2025 | — |
| EFFECT | — | 9999999995-25-000044 | Jan 7, 2025 | — |
| 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-25-001726 | Jan 7, 2025 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-25-001208 | Jan 6, 2025 | — |
| CORRESP | — | 0001213900-25-000704 | Jan 3, 2025 | — |
| CORRESP | — | 0001213900-25-000703 | Jan 3, 2025 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-24-106894 | Dec 9, 2024 | — |